(CTCs) (NGS) Circulating tumor cells Liquid biopsy Next generation sequencing

Journal

Biochemistry and biophysics reports
ISSN: 2405-5808
Titre abrégé: Biochem Biophys Rep
Pays: Netherlands
ID NLM: 101660999

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 22 05 2024
revised: 23 07 2024
accepted: 02 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

In metastatic breast cancer (MBC), blood is a source of circulating tumor cells (CTCs). CTCs may serve as a ''real-time liquid biopsy" as they represent metastatic tumor genetics better than primary tumor.

Identifiants

pubmed: 39282094
doi: 10.1016/j.bbrep.2024.101805
pii: S2405-5808(24)00169-9
pmc: PMC11396050
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101805

Informations de copyright

© 2024 The Authors. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Elena Marino (E)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Laboratory of Medical Genetics, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.

Cristian Mauro (C)

Laboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Elena Belloni (E)

Department of Experimental Oncology, Istituto Europeo di Oncogia, IRCCS, Milan, Italy.

Marco Picozzi (M)

Laboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Valentina Favalli (V)

4Basessrl, Pavia, Italy.

Maria Cristina Cassatella (MC)

Laboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Laura Zorzino (L)

Laboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Luciano Giacò (L)

Bioinformatics Core Facility, Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy.

Pier Giuseppe Pelicci (PG)

Department of Experimental Oncology, Istituto Europeo di Oncogia, IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Italy.

Massimo Barberis (M)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Maria Teresa Sandri (MT)

Laboratorio Bianalisi, Carate Brianza, MB, Italy.

Loris Bernard (L)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Classifications MeSH